APA (7th ed.) Citation

Hurwitz, S. J., De, R., LeCher, J. C., Downs-Bowen, J. A., Goh, S. L., Zandi, K., . . . Schinazi, R. F. (2024). Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections. Viruses (1999-4915), 16(4), 651. https://doi.org/10.3390/v16040651

Chicago Style (17th ed.) Citation

Hurwitz, Selwyn J., et al. "Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections." Viruses (1999-4915) 16, no. 4 (2024): 651. https://doi.org/10.3390/v16040651.

MLA (9th ed.) Citation

Hurwitz, Selwyn J., et al. "Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections." Viruses (1999-4915), vol. 16, no. 4, 2024, p. 651, https://doi.org/10.3390/v16040651.